Top compounds associated with response to GPD2


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CCLE pan-cancer AAC 0.17 0.0008
mRNA CP466722 GDSC1000 pan-cancer AAC -0.11 0.0008
mRNA SNX-2112 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA BX-795 GDSC1000 pan-cancer AAC -0.13 0.001
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC -0.12 0.001
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.13 0.001
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.13 0.002
mRNA PL-DI CTRPv2 pan-cancer AAC -0.11 0.002
mRNA AZD6244 CCLE pan-cancer AAC 0.15 0.002
Download CSV